Revelation Biosciences, Inc. Warrant (REVBW) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Revelation Biosciences, Inc. Warrant (REVBW:NASDAQ), powered by AI.

Current Price
$0.01
Sector
Healthcare
What is the Revelation Biosciences, Inc. Warrant stock price forecast?

Revelation Biosciences, Inc. Warrant is currently trading at $0.01. View real-time AI analysis on Alpha Lenz.

What is Revelation Biosciences, Inc. Warrant insider trading activity?

View the latest insider trading data for Revelation Biosciences, Inc. Warrant on Alpha Lenz.

What is Revelation Biosciences, Inc. Warrant's P/E ratio?

View Revelation Biosciences, Inc. Warrant's valuation metrics on Alpha Lenz.

Revelation Biosciences, Inc. Warrant

NASDAQ · REVBW
$0.01+0.00(+1.10%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Revelation Biosciences, Inc. Warrant's future dividend policy...
Alpha Chat Insight

Revelation Biosciences, Inc. Warrant's ROE is -131.4%. Explore profitability and growth together.

Ask for details

Company Overview

Revelation Biosciences, Inc. Warrant represents a financial instrument that provides the holder the opportunity to purchase shares of Revelation Biosciences, Inc. at a predetermined price before expiration. Warrants are typically used by companies to raise capital in conjunction with the issuance of new equity, providing investors with a leveraged exposure to the company's stock potential. Revelation Biosciences, Inc. focuses on developing diagnostic and therapeutic products aimed at addressing a range of respiratory and inflammatory conditions, which are of significant relevance in the healthcare sector. The warrants offer investors a means to participate in the company's future growth prospects without initially purchasing the underlying stock. By aligning with Revelation Biosciences’ innovation in respiratory health technologies, these warrants play an essential role in the financial strategy of investors looking to tap into cutting-edge healthcare solutions. Overall, the warrant signifies an intersection of financial strategy and biotechnology advancement, underscoring its role in both capital markets and the broader healthcare innovation landscape.

CEOMr. James M. Rolke
SectorHealthcare
IndustryBiotechnology
Employees8

Company Statistics

FY 2025

Profile

N/AMarket Cap
$0.00Revenue
0.00Shares Out
8Employees

Margins

N/AGross
N/AEBITDA
N/AOperating
N/APre-Tax
N/ANet

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-97.93%ROA
-131.38%ROE
-99.65%ROIC

Financial Health

$10.70MCash & Cash Equivalents
$-7.98MNet Debt
30.72%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Revelation Biosciences, Inc. Warrant (ticker: REVBW) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 8 employees.

The current price is $0.009 with a P/E ratio of -x and P/B of -x.

ROE is -131.38%.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Revelation Biosciences, Inc. Warrant (REVBW) Stock Forecast 2026 $0.01 — Price, Financials & Analyst Targets | Alpha Lenz